Utah Medical Products, Inc. (UTMD)
USD 62.0
(-0.85%)
USD 62.0
(-0.85%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 50.22 Million USD | -3.93% |
| 2022 | 52.28 Million USD | 6.58% |
| 2021 | 49.05 Million USD | 16.3% |
| 2020 | 42.17 Million USD | -10.08% |
| 2019 | 46.9 Million USD | 11.68% |
| 2018 | 41.99 Million USD | 1.41% |
| 2017 | 41.41 Million USD | 5.38% |
| 2016 | 39.29 Million USD | -2.14% |
| 2015 | 40.15 Million USD | -2.72% |
| 2014 | 41.27 Million USD | 1.94% |
| 2013 | 40.49 Million USD | -2.55% |
| 2012 | 41.55 Million USD | 9.75% |
| 2011 | 37.86 Million USD | 50.71% |
| 2010 | 25.12 Million USD | -3.07% |
| 2009 | 25.91 Million USD | -6.72% |
| 2008 | 27.78 Million USD | -2.53% |
| 2007 | 28.5 Million USD | -0.87% |
| 2006 | 28.75 Million USD | 3.83% |
| 2005 | 27.69 Million USD | 4.56% |
| 2004 | 26.48 Million USD | -2.4% |
| 2003 | 27.13 Million USD | -0.82% |
| 2002 | 27.36 Million USD | 1.51% |
| 2001 | 26.95 Million USD | -0.88% |
| 2000 | 27.19 Million USD | -7.65% |
| 1999 | 29.44 Million USD | 6.3% |
| 1998 | 27.7 Million USD | 13.99% |
| 1997 | 24.3 Million USD | -37.21% |
| 1996 | 38.7 Million USD | -7.86% |
| 1995 | 42 Million USD | 6.06% |
| 1994 | 39.6 Million USD | 7.03% |
| 1993 | 37 Million USD | 2.49% |
| 1992 | 36.1 Million USD | 21.14% |
| 1991 | 29.8 Million USD | 24.69% |
| 1990 | 23.9 Million USD | 33.52% |
| 1989 | 17.9 Million USD | 32.59% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 10 Million USD | -3.8% |
| 2024 Q2 | 10.4 Million USD | -8.29% |
| 2024 Q1 | 11.34 Million USD | -8.05% |
| 2023 Q2 | 12.86 Million USD | 175.09% |
| 2023 FY | 50.22 Million USD | -3.93% |
| 2023 Q3 | 12.5 Million USD | -2.81% |
| 2023 Q4 | 12.33 Million USD | -1.38% |
| 2023 Q1 | 4.67 Million USD | -65.55% |
| 2022 FY | 52.28 Million USD | 6.58% |
| 2022 Q1 | 12.32 Million USD | -4.58% |
| 2022 Q4 | 13.57 Million USD | 4.79% |
| 2022 Q2 | 13.42 Million USD | 8.97% |
| 2022 Q3 | 12.95 Million USD | -3.52% |
| 2021 Q1 | 10.96 Million USD | -8.71% |
| 2021 FY | 49.05 Million USD | 16.3% |
| 2021 Q4 | 12.91 Million USD | 2.72% |
| 2021 Q3 | 12.57 Million USD | -0.25% |
| 2021 Q2 | 12.6 Million USD | 14.96% |
| 2020 FY | 42.17 Million USD | -10.08% |
| 2020 Q1 | 10.9 Million USD | -7.85% |
| 2020 Q3 | 10.47 Million USD | 19.26% |
| 2020 Q4 | 12.01 Million USD | 14.61% |
| 2020 Q2 | 8.78 Million USD | -19.4% |
| 2019 Q4 | 11.83 Million USD | -5.31% |
| 2019 Q1 | 10.73 Million USD | 10.0% |
| 2019 FY | 46.9 Million USD | 11.68% |
| 2019 Q2 | 11.84 Million USD | 10.38% |
| 2019 Q3 | 12.49 Million USD | 5.47% |
| 2018 FY | 41.99 Million USD | 1.41% |
| 2018 Q1 | 10.88 Million USD | 6.72% |
| 2018 Q3 | 10.39 Million USD | -5.24% |
| 2018 Q4 | 9.75 Million USD | -6.1% |
| 2018 Q2 | 10.96 Million USD | 0.72% |
| 2017 Q4 | 10.2 Million USD | 0.75% |
| 2017 Q2 | 10.82 Million USD | 5.56% |
| 2017 FY | 41.41 Million USD | 5.38% |
| 2017 Q1 | 10.25 Million USD | 15.89% |
| 2017 Q3 | 10.12 Million USD | -6.5% |
| 2016 FY | 39.29 Million USD | -2.14% |
| 2016 Q1 | 10.3 Million USD | 7.5% |
| 2016 Q2 | 10.49 Million USD | 1.83% |
| 2016 Q3 | 9.65 Million USD | -7.96% |
| 2016 Q4 | 8.85 Million USD | -8.32% |
| 2015 Q3 | 9.94 Million USD | -4.35% |
| 2015 FY | 40.15 Million USD | -2.72% |
| 2015 Q2 | 10.39 Million USD | 1.6% |
| 2015 Q1 | 10.23 Million USD | -0.1% |
| 2015 Q4 | 9.58 Million USD | -3.65% |
| 2014 Q2 | 10.49 Million USD | 6.76% |
| 2014 Q4 | 10.24 Million USD | -4.42% |
| 2014 FY | 41.27 Million USD | 1.94% |
| 2014 Q3 | 10.71 Million USD | 2.15% |
| 2014 Q1 | 9.82 Million USD | -2.56% |
| 2013 Q1 | 10.37 Million USD | 5.5% |
| 2013 FY | 40.49 Million USD | -2.55% |
| 2013 Q2 | 10 Million USD | -3.59% |
| 2013 Q3 | 10.03 Million USD | 0.3% |
| 2013 Q4 | 10.08 Million USD | 0.53% |
| 2012 Q1 | 11.2 Million USD | 13.12% |
| 2012 FY | 41.55 Million USD | 9.75% |
| 2012 Q3 | 10.48 Million USD | 4.63% |
| 2012 Q2 | 10.02 Million USD | -10.54% |
| 2012 Q4 | 9.83 Million USD | -6.25% |
| 2011 Q1 | 6.79 Million USD | 9.41% |
| 2011 Q4 | 9.9 Million USD | -8.14% |
| 2011 Q2 | 10.37 Million USD | 52.76% |
| 2011 Q3 | 10.78 Million USD | 3.92% |
| 2011 FY | 37.86 Million USD | 50.71% |
| 2010 FY | 25.12 Million USD | -3.07% |
| 2010 Q4 | 6.2 Million USD | 0.13% |
| 2010 Q3 | 6.2 Million USD | -1.2% |
| 2010 Q2 | 6.27 Million USD | -2.49% |
| 2010 Q1 | 6.43 Million USD | -0.86% |
| 2009 Q4 | 6.49 Million USD | -2.71% |
| 2009 FY | 25.91 Million USD | -6.72% |
| 2009 Q3 | 6.67 Million USD | 5.84% |
| 2009 Q2 | 6.3 Million USD | -2.17% |
| 2009 Q1 | 6.44 Million USD | -2.3% |
| 2008 Q1 | 6.89 Million USD | -2.63% |
| 2008 Q3 | 7.18 Million USD | 0.93% |
| 2008 Q4 | 6.59 Million USD | -8.13% |
| 2008 FY | 27.78 Million USD | -2.53% |
| 2008 Q2 | 7.11 Million USD | 3.27% |
| 2007 FY | 28.5 Million USD | -0.87% |
| 2007 Q4 | 7.07 Million USD | -0.3% |
| 2007 Q3 | 7.09 Million USD | -1.58% |
| 2007 Q2 | 7.21 Million USD | 1.31% |
| 2007 Q1 | 7.11 Million USD | -3.22% |
| 2006 FY | 28.75 Million USD | 3.83% |
| 2006 Q1 | 7.1 Million USD | 1.33% |
| 2006 Q2 | 7.29 Million USD | 2.66% |
| 2006 Q4 | 7.35 Million USD | 5.06% |
| 2006 Q3 | 7 Million USD | -4.0% |
| 2005 FY | 27.69 Million USD | 4.56% |
| 2005 Q4 | 7.01 Million USD | 0.14% |
| 2005 Q3 | 7 Million USD | -0.38% |
| 2005 Q2 | 7.02 Million USD | 5.65% |
| 2005 Q1 | 6.65 Million USD | 4.39% |
| 2004 Q2 | 6.82 Million USD | 3.19% |
| 2004 Q3 | 6.67 Million USD | -2.3% |
| 2004 Q4 | 6.37 Million USD | -4.47% |
| 2004 FY | 26.48 Million USD | -2.4% |
| 2004 Q1 | 6.61 Million USD | -0.65% |
| 2003 Q2 | 6.84 Million USD | -0.54% |
| 2003 Q4 | 6.65 Million USD | -1.51% |
| 2003 FY | 27.13 Million USD | -0.82% |
| 2003 Q1 | 6.87 Million USD | 0.38% |
| 2003 Q3 | 6.76 Million USD | -1.15% |
| 2002 FY | 27.36 Million USD | 1.51% |
| 2002 Q1 | 6.7 Million USD | -1.43% |
| 2002 Q2 | 6.8 Million USD | 1.42% |
| 2002 Q3 | 7 Million USD | 3.01% |
| 2002 Q4 | 6.85 Million USD | -2.2% |
| 2001 Q2 | 6.79 Million USD | 3.46% |
| 2001 Q3 | 6.79 Million USD | -0.04% |
| 2001 Q4 | 6.8 Million USD | 0.16% |
| 2001 FY | 26.95 Million USD | -0.88% |
| 2001 Q1 | 6.56 Million USD | -1.84% |
| 2000 Q2 | 6.95 Million USD | 4.35% |
| 2000 Q3 | 6.88 Million USD | -1.06% |
| 2000 Q4 | 6.69 Million USD | -2.79% |
| 2000 Q1 | 6.66 Million USD | -11.64% |
| 2000 FY | 27.19 Million USD | -7.65% |
| 1999 Q2 | 7.3 Million USD | 4.29% |
| 1999 Q3 | 7.6 Million USD | 4.11% |
| 1999 Q4 | 7.54 Million USD | -0.74% |
| 1999 Q1 | 7 Million USD | -5.41% |
| 1999 FY | 29.44 Million USD | 6.3% |
| 1998 Q4 | 7.4 Million USD | 2.78% |
| 1998 FY | 27.7 Million USD | 13.99% |
| 1998 Q1 | 6.4 Million USD | -8.57% |
| 1998 Q2 | 6.8 Million USD | 6.25% |
| 1998 Q3 | 7.2 Million USD | 5.88% |
| 1997 Q2 | 5.1 Million USD | -1.92% |
| 1997 Q4 | 7 Million USD | 0.0% |
| 1997 Q3 | 7 Million USD | 37.25% |
| 1997 FY | 24.3 Million USD | -37.21% |
| 1997 Q1 | 5.2 Million USD | -39.53% |
| 1996 FY | 38.7 Million USD | -7.86% |
| 1996 Q4 | 8.6 Million USD | -14.0% |
| 1996 Q3 | 10 Million USD | -0.99% |
| 1996 Q2 | 10.1 Million USD | 1.0% |
| 1996 Q1 | 10 Million USD | -7.41% |
| 1995 Q1 | 9.8 Million USD | -2.97% |
| 1995 Q2 | 10.7 Million USD | 9.18% |
| 1995 FY | 42 Million USD | 6.06% |
| 1995 Q4 | 10.8 Million USD | 0.93% |
| 1995 Q3 | 10.7 Million USD | 0.0% |
| 1994 Q1 | 9.4 Million USD | 3.3% |
| 1994 FY | 39.6 Million USD | 7.03% |
| 1994 Q4 | 10.1 Million USD | 1.0% |
| 1994 Q3 | 10 Million USD | -0.99% |
| 1994 Q2 | 10.1 Million USD | 7.45% |
| 1993 Q3 | 9.4 Million USD | -1.05% |
| 1993 Q4 | 9.1 Million USD | -3.19% |
| 1993 Q1 | 9 Million USD | -7.22% |
| 1993 FY | 37 Million USD | 2.49% |
| 1993 Q2 | 9.5 Million USD | 5.56% |
| 1992 FY | 36.1 Million USD | 21.14% |
| 1992 Q3 | 9.4 Million USD | 5.62% |
| 1992 Q1 | 8.1 Million USD | 0.0% |
| 1992 Q4 | 9.7 Million USD | 3.19% |
| 1992 Q2 | 8.9 Million USD | 9.88% |
| 1991 Q2 | 7.2 Million USD | 10.77% |
| 1991 FY | 29.8 Million USD | 24.69% |
| 1991 Q4 | 8.1 Million USD | 2.53% |
| 1991 Q3 | 7.9 Million USD | 9.72% |
| 1991 Q1 | 6.5 Million USD | -8.45% |
| 1990 Q3 | 6.5 Million USD | 20.37% |
| 1990 Q2 | 5.4 Million USD | 8.0% |
| 1990 Q1 | 5 Million USD | -9.09% |
| 1990 Q4 | 7.1 Million USD | 9.23% |
| 1990 FY | 23.9 Million USD | 33.52% |
| 1989 Q4 | 5.5 Million USD | 19.57% |
| 1989 Q2 | 4 Million USD | 5.26% |
| 1989 Q1 | 3.8 Million USD | -15.56% |
| 1989 Q3 | 4.6 Million USD | 15.0% |
| 1989 FY | 17.9 Million USD | 32.59% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 48.026% |
| AngioDynamics, Inc. | 303.91 Million USD | 83.474% |
| AtriCure, Inc. | 399.24 Million USD | 87.42% |
| Avinger, Inc. | 7.65 Million USD | -556.351% |
| Azenta, Inc. | 665.07 Million USD | 92.448% |
| BioLife Solutions, Inc. | 143.27 Million USD | 64.945% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 98.602% |
| Daxor Corporation | 1.28 Million USD | -3822.172% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -174.763% |
| Femasys Inc. | 1.07 Million USD | -4585.206% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 55.257% |
| Hologic, Inc. | 4.03 Billion USD | 98.754% |
| ICU Medical, Inc. | 2.25 Billion USD | 97.777% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 99.295% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -76.115% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 74.042% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -4257.91% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -4257.91% |
| Masimo Corporation | 2.04 Billion USD | 97.548% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 48.275% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 96.006% |
| Nephros, Inc. | 14.23 Million USD | -252.746% |
| NovoCure Limited | 509.33 Million USD | 90.139% |
| NEXGEL, Inc. | 4.08 Million USD | -1128.271% |
| NEXGEL, Inc. | 4.08 Million USD | -1128.271% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -1625.318% |
| OraSure Technologies, Inc. | 405.47 Million USD | 87.613% |
| Pro-Dex, Inc. | 53.84 Million USD | 6.723% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -2721.426% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -162.893% |
| QuidelOrtho Corporation | 2.99 Billion USD | 98.325% |
| Repligen Corporation | 638.76 Million USD | 92.137% |
| Sanara MedTech Inc. | 64.98 Million USD | 22.72% |
| STAAR Surgical Company | 322.41 Million USD | 84.423% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 98.733% |
| Jin Medical International Ltd. | 19.82 Million USD | -153.382% |